The Han Lab Publications

Selected Publications

Choi, E., Ding, V.Y., Luo, S.J., ten Haaf, K., Wu, J.T. Aredo, J.V., Wilkens, L.R., Freedman, N.D., Backhus, L.M.,Leung, A.N., Meza R., Lui, N. S., Haiman, C.A., Park, S.L., LLe Marchand, L., Neal, J.W., Cheng, I., Wakelee, H.A., Tammemägi, M.C., and Han, S.S. (2023) Risk Model–Based Lung Cancer Screening and Racial and Ethnic Disparities in the US. JAMA Oncology

*Fries, A.H., *Choi, E., Wu, J.T., Lee, J.H., Ding, V.Y., Huang, R.J., Liang, S.Y., Wakelee, H.A., Wilkens, L.R., Cheng, I. and Han, S.S., (2023) Software Application Profile: dynamicLM—a tool for performing dynamic risk prediction using a landmark supermodel for survival data under competing risksInternational Journal of Epidemiology, p.dyad122.

*Choi, E., *Su, C.C., Wu, J.T., Aredo, J.V., Neal, J.W., Leung, A. N., Backhus, L.M., Lui, N.S., Le Marchand, L., Stram, D.O., Liang, S.Y., Cheng, I., Wakelee, H.A., Han, S.S. (2023) Second Primary Lung Cancer among Lung Cancer Survivors Who Never SmokedJAMA Network Open6 (11), e2343278-e2343278

Choi E., Luo, S.J. Ding, V.Y., Wu, J.T., Kumar, A.V., Wampfler, J., Tammemägi, M.C., Wilkens, L.R., Aredo, J.V., Backhus, L.M., Neal, J.W.,Leung, A. N., Freedman, N.D., Hung, R. J., Amos, C.I., Le Marchand, L., Cheng, I., Wakelee, H.A., Yang, P., and Han, S.S. (2023) Risk Model-Based Management for Second Primary Lung Cancer Among Lung Cancer Survivors Through A Validated Risk Prediction ModelCancer

Su, C.C., Wu, J.T., Choi, E., Myall, N.J., Neal, J.W., Kurian, A.W., Stehr, H., Wood, D., Henry, S.M., Backhus, L.M. Leung, A.N., Wakelee, H.A, and Han, S.S. (2023) Overall Survival Among PatientsWith De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non–Small Cell Lung CancerJAMA Network Open, 6(9), pp.e2335813-e2335813.

Wu, J.T.Y., Wakelee, H.A. and Han, S.S., (2023) Optimizing Lung Cancer Screening With Risk Prediction: Current Challenges and the Emerging Role of Biomarkers. Journal of Clinical Oncology, pp.JCO-23.

Toumazis, I.,  Cao*, P.,  de Nijs*, K., Bastani*, M.,   Munshi, V.,   Hemmati, M.,   ten Haaf, K.,   Jeon, J., Tammemägi, M., Gazelle, G.S., Feuer, E.J.,   Kong, C.Y., Meza, R., de Koning, H.J.  Plevritis, S.K., and Han, S.S. (2023) Risk Model–Based Lung Cancer Screening: A Cost-Effectiveness Analysis. Annals of Internal Medicine

Wu, J., Ding, V., Luo, S., Choi, E., Hellyer, J., Myall, N., Henry, S., Wood, D., Stehr, H., Ji, H. and Nagpal, S., Gephart, M., Wakelee, H., Neal, J., and Han, S.S. 2022.  Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World Outcomes. JCO Precision Oncology, 6, p.e2200220.

Aredo, J.V., Choi, E., Ding, V.Y., Tammemägi, M.C., Ten Haaf, K., Luo, S.J., Freedman, N.D., Wilkens, L.R., Le Marchand, L., Wakelee, H.A. and Meza, Park, S., Cheng, I., Han, S.S. 2022. Racial and ethnic disparities in lung cancer screening by the 2021 USPSTF guidelines versus risk-based criteria: the Multiethnic Cohort Study. JNCI Cancer Spectrum, 6(3), p.pkac033.

*Choi, E., *Luo, S.J., Aredo, J.V., Backhus, L.M., Wilkens, L.R., Su, C.C., Neal, J.W., Le Marchand, L., Cheng, I., Wakelee, H.A. and Han, S.S. (2021) The Survival Impact of Second Primary Lung Cancer in Patients with Lung Cancer. JNCI: Journal of the National Cancer Institute

Toumazis, I., de Nijs, K., Cao, P., Bastani, M., Munshi, V., Ten Haaf, K., Jeon, J., Gazelle, G.S., Feuer, E.J., de Koning, H.J., Meza, R., Kong, C., *Han S.S., *Plevritis, S.K. (2021) Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening. JAMA oncology. *Co-Corresponding Authors

Choi, E., Sanyal, N., Ding, V.Y., Gardner, R.M., Aredo, J.V., Lee, J., Wu, J.T., Hickey, T.P., Barrett, B., Riley, T.L., Wilkens, L.R., Leung, A.N., Le Marchand, L., Tammemägi, M., Hung, R.J., Amos, C.I., Freedman, N.D., Cheng, I., Wakelee, H.A., Han, S.S. (2021) Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer. Journal of National Cancer Institute  

Aredo, J.V., Wakelee, H.W., Han, S.S. (2021) A Moving Target: Integration of Smoking Cessation into Screening for Second Primary Lung Cancer. Journal of Thoracic Oncology (Letter to the editor)

Su, C.C., Wu., J.T., Neal, J.W., Popat, R.A., Kurian, A.W., Backhus, L.M., Nagpal S., Leung, A.N., Wakelee, H.A., Han, S.S., (2021) Impact of Low-Dose CT Screening for Primary Lung Cancer on Subsequent Risk of Brain Metastasis.  Journal of Thoracic Oncology 

Aredo, J.V., Luo, S., Gardner, R.M., Sanyal, N., Choi, E., Hickey, T.P., Riley, T.L., Huang, W., Kurian, A.W., Leung, A.N., Wilkens, L.R., Le Marchand, L., Amos, C.I., Hung, R.J., Freedman, N.D., Johansson, M., Robbins, H.A., Riboli, E., Rudolf Kaaks, R., Tjønneland A., Vermeulen, R.C.H., Panico, S., Cheng, I., Wakelee, H.W., Han, S.S. (2021) Tobacco Smoking and Risk of Second Primary Lung Cancer. Journal of Thoracic Oncology

Luo, S.J., Choi, E., Aredo, J.V., Wilkens, L.R., Tammemägi, M.C., Le Marchand, L., Cheng, I., Wakelee, H.A. and Han, S.S., 2021. Smoking Cessation After Lung Cancer Diagnosis and the Risk of Second Primary Lung Cancer: The Multiethnic Cohort Study. JNCI cancer spectrum, 5(5), p.pkab076.

Sanyal, N., Napolioni, V., de Rochemonteix, M., Belloy,M.E., Caporaso, N.E., Landi, M.T., Michael D. Greicius, M.D., Chatterjee, N., Han, S.S. (2021) A robust test for additive gene-environment interaction under the trend effect of genotype using an empirical Bayes-type shrinkage estimator. American Journal of Epidemiology

Aredo, J. V., Purington, N., Su, L., Luo, S. J., Diao, N., Christiani, D. C., Wakelee*, H. A, Han, S.S* Metabolomic Profiling for Second Primary Lung Cancer: A Pilot Case-Control Study. (2021) Lung Cancer 

de Rochemonteix, M., Napolioni, V., Sanyal, N., Belloy M.E., Caporaso, Landi, M.T., Greicius, M.D., Chatterjee, N., and Han, S.S. (2020) A likelihood ratio test for gene-environment interaction based on the trend effect of genotype under an additive risk model using the gene-environment independence assumption. American Journal of Epidemiology.

Han, S.S., Chow, E., ten Haaf, K., Toumazis, I., Bastani, M., Tammemagi. M., Jeon, J., Meza, R., Plevritis, S.K. (2020) Disparities and national lung screening guidelines in the U.S. population. Journal of National Cancer Institute.

Han, S.S., Azad, T.D., Suarez, P.A. and Ratliff, J.K., (2019) A machine learning approach for predictive models of adverse events following spine surgeryThe Spine Journal.

Han, S.S., Kelly, S.P., Yang, B., Li, Y., Nguyen, M.H., So, S.K , Rosenberg, P.S., and Hsing, A.W., (2018) Changing landscape of liver cancer in California: a glimpse into the future of liver cancer in the United States. Journal of the National Cancer Institute

Han, S.S., Plevritis, S.K. and Wakelee, H.A., (2018) Caution Needed for Analyzing the Risks of Second Cancers. Journal of Thoracic Oncology, 13(9), pp.e172-e173

Han, S. S., & Chatterjee, N. (2018). Review of Statistical Methods for Gene-Environment Interaction Analysis. Current Epidemiology Reports, 1-7.

Han, S. S., Kevin ten Haaf, WD Hazelton, J Jeon, RMeza, CY Kong, EJ Feuer, HJ de Koning, SK Plevritis (2017) Re: Think Before You Leap  International Journal of Cancer (In press)

Han, S.S., Raymond J. Carroll, and Nilanjan Chatterjee (2017) Book Chapter: Analysis of Gene- Environment Interactions; Handbook of Statistical Methods for Case-Control Studies (Chapman & Hall) (In Press)

Han, S.S., Rivera G.A.,Tammemägi M.C., Plevritis S.K., Cheng I, Gomez S.L., Wakelee H.A. Risk-Stratification for Second Primary Lung Cancer. (2017) Journal of Clinical Oncology

Han, S. S., I. Toumazis, S. A. Erdogan, A. Leung & S. K. Plevritis (2017) Evaluating the Impact of Varied Compliance to Lung Cancer Screening Recommendations using a Microsimulation Model. Cancer Causes and Control.

Han, S. S., K. ten Haaf, W. D. Hazelton, V. N. Munshi, J. Jeon, S. A. Erdogan, C. Johanson, P. M. McMahon, R. Meza & C. Y. Kong (2017) The impact of overdiagnosis on the selection of efficient lung cancer screening strategies. International Journal of Cancer.